Pdt Partners, LLC Novo Cure LTD Transaction History
Pdt Partners, LLC
- $1 Billion
- Q4 2024
A detailed history of Pdt Partners, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Pdt Partners, LLC holds 80,232 shares of NVCR stock, worth $1.75 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
80,232
Previous 112,083
28.42%
Holding current value
$1.75 Million
Previous $1.75 Million
36.49%
% of portfolio
0.24%
Previous 0.17%
Shares
7 transactions
Others Institutions Holding NVCR
# of Institutions
289Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$265 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$257 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$194 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$105 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$59.8 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.29B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...